Surgical therapy for diabesity

Mount Sinai Journal of Medicine

Volumn 77, Issue 5, 2010, Pages 418-430

  Arroyo, Kervin ^a   Kini, Subhash U ^a   Harvey, John E ^a   Herron, Daniel M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

bariatric surgery; biliopancreatic diversion; duodenal jejunal bypass; gastric band; ileal interposition; Roux en Y bypass; sleeve gastrectomy; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; COMPARATIVE STUDY; DIABETIC OBESITY; FOLLOW UP; GASTRECTOMY; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HORMONAL REGULATION; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INTESTINE BYPASS; MALABSORPTION; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; TREATMENT OUTCOME;

EID: 78449249726     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20209     Document Type: Review

References (89)

1. Wild S, Roglic G, Green A, et al., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047 - 1053.
2. Narayan KM, Boyle JP, Geiss LS, et al., Impact of recent increase in incidence on future diabetes burden: U.S. 2005-2050. Diabetes Care 2006; 29: 2114 - 2116.
3. Zimmet P, Alberti KG, Shaw J., Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782 - 787.
4. From the NIH: successful diet and exercise therapy is conducted in Vermont for "diabesity." JAMA 1980; 243: 519 - 520.
5. National Center for Health Statistics, US Department of Health and Human Services. Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994, laboratory data file (CD-ROM). Hyattsville, MD: Centers for Disease Control and Prevention; 1996. Public use data file 76200. Available from National Technical Information Service (NTIS), Springfield, VA.
6. Ogden CL, Carroll MD, Curtin LR, et al., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549 - 1555.
7. National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health; 2000. NIH publication 00-4084.
8. National Institutes of Health, US Department of Health and Human Services. Gastrointestinal surgery for severe obesity. Consensus Statement of the NIH Consensus Development Conference, March 25-27, 1991. Accessed 3 September 2010.
9. Friedman MN, Sancetta AJ, Magovern GJ., The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 1955; 100: 201 - 204.
10. Mason EE, Ito C., Gastric bypass in obesity: 1967 [1996 reprint]. Obes Res 1996; 4: 316 - 319.
11. Santry HP, Gillen DL, Lauderdale DS., Trends in bariatric surgical procedures. JAMA 2005; 294: 1909 - 1917.
12. Adams TD, Gress RE, Smith SC, et al., Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753 - 761.
13. Buchwald H, Oien DM., Metabolic/bariatric surgery worldwide 2008. Obes Surg 2009; 19: 1605 - 1611.
14. Kashyap SR, Daud S, Kelly KR, et al., Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010; 34: 462 - 471.
15. Pories WJ, Swanson MS, MacDonald KG, et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339 - 352.
16. Schauer PR, Burguera B, Ikramuddin S, et al., Effect of laparoscopic Roux-en Y gastric bypass on diabetes mellitus. Ann Surg 2003; 238: 467 - 484.
17. Sugerman HJ, Wolfe LG, Sica DA, Clore JN,. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751 - 756.
18. MacDonald KG Jr, Long SD, Swanson MS, et al., The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213 - 220.
19. Christou NV, Sampalis JS, Liberman M, et al., Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416 - 424.
20. Buchwald H, Estok R, Fahrbach K, et al., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248 - 256.
21. Sjöström L, Lindroos AK, Peltonen M, et al., Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683 - 2693.
22. Torquati A, Lutfi R, Abumrad N, Richards WO., Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 2005; 9: 1112 - 1118.
23. DiGiorgi M, Rosen DJ, Choi JJ, et al., Re-emergence of diabetes after gastric bypass inpatients with mid-to long-term follow-up. Surg Obes Relat Dis 2010; 6: 249 - 253.
24. O'Brien PE, Dixon JB., Lap-band: outcomes and results. J Laparoendosc Adv Surg Tech A 2003; 13: 265 - 270.
25. Ren CJ, Weiner M, Allen JW., Favorable early results of gastric banding for morbid obesity: the American experience. Surg Endosc 2004; 18: 543 - 546.
26. Ponce J, Paynter S, Fromm R., Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 2005; 201: 529 - 535.
27. Ponce J, Dixon JB., Laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2005; 1: 310 - 316.
28. Dixon JB, O'Brien PE., Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358 - 363.
29. Dixon JB, O'Brien PE, Playfair J, et al., Adjustable gastric banding and conventional therapy for type 2 diabetes. JAMA 2008; 299: 316 - 323.
30. Ponce J, Haynes B, Paynter S, et al., Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 2004; 14: 1335 - 1342.
31. Marceau P, Hould FS, Simard S, et al., Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947 - 954.
32. Hess DS, Hess DW., Biliopancreatic diversion with a duodenal switch. Obes Surg 1998; 8: 267 - 282.
33. Anthone GJ, Lord RV, DeMeester TR, et al., The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003; 238: 618 - 627.
34. Ren CJ, Patterson E, Gagner M., Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000; 10: 514 - 523.
35. Scopinaro N, Adami GF, Marinari GM, et al., Biliopancreatic diversion. World J Surg 1998; 22: 936 - 946.
36. Rabkin RA, Rabkin JM, Metcalf B, et al., Laparoscopic technique for performing duodenal switch with gastric reduction. Obes Surg 2003; 13: 263 - 268.
37. Strain GW, Gagner M, Pomp A, et al., Comparison of weight loss and body composition changes with four surgical procedures. Surg Obes Relat Dis 2009; 5: 582 - 587.
38. Scopinaro N, Papadia F, Camerini G, et al., A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations. Obes Surg 2008; 18: 1035 - 1038.
39. Buchwald H, Avidor Y, Braunwald E, et al., Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724 - 1737.
40. Regan JP, Inabnet WB, Gagner M, Pomp A., Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003; 13: 861 - 864.
41. Bohdjalian A, Langer FB, Shakeri-Leidenmühler S, et al., Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg 2010; 20: 535 - 540.
42. Sammour T, Hill AG, Singh P, et al., Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure. Obes Surg 2010; 20: 271 - 275.
43. Sénchez-Santos R, Masdevall C, Baltasar A, et al., Short-and mid-term outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg 2009; 19: 1203 - 1210.
44. Armstrong J, O'Malley SP., Outcomes of sleeve gastrectomy for morbid obesity: a safe and effective procedure? Int J Surg 2010; 8: 69 - 71.
45. Jacobs M, Bisland W, Gomez E, et al., Laparoscopic sleeve gastrectomy: a retrospective review of 1-and 2-year results. Surg Endosc 2010; 24: 781 - 785.
46. Arias E, Martínez PR, Ka Ming Li V, et al., Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity. Obes Surg 2009; 19: 544 - 548.
47. Gagner M, Deitel M, Kalberer TL, et al., The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg Obes Relat Dis 2009; 5: 476 - 485.
48. Cottam D, Qureshi FG, Mattar SG, et al., Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006; 20: 859 - 886.
49. Silecchia G, Boru C, Pecchia A, et al., Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg 2006; 16: 1138 - 1144.
50. Vidal J, Ibarzabal A, Romero F, et al., Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077 - 1082.
51. Gan SS, Talbot ML, Jorgensen JO., Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg 2007; 77: 958 - 962.
52. Herron DM, Tong W., Role of surgery in management of type 2 diabetes mellitus. Mt Sinai J Med 2009; 76: 281 - 293.
53. Peterli R, Wölnerhanssen B, Peters T, et al., Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Ann Surg 2009; 250: 234 - 241.
54. Rubino F, Schauer PR, Kaplan LM, et al., Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393 - 411.
55. Thaler JP, Cummings DE., Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518 - 2525.
56. Sugerman HJ, Londrey GL, Kellum JM, et al., Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989; 157: 93 - 102.
57. Laferrère B, Teixeira J, McGinty J, et al., Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479 - 2485.
58. Rubino F, Forgione A, Cummings DE, et al., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741 - 749.
59. Mason EE., Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999; 9: 223 - 228.
60. Mason EE., The mechanisms of surgical treatment of type 2 diabetes mellitus. Obes Surg 2005; 15: 459 - 461.
61. Wang TT, Hu SY, Gao HD, et al., Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 2008; 247: 968 - 975.
62. Frezza EE., Are we closer in finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? Obes Surg 2004; 14: 999 - 1005.
63. Rubino F, Zizzari P, Tomasetto C, et al., The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 2005; 146: 1745 - 1751.
64. Strader AD, Vahl TP, Jandacek RJ, et al., Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 2005; 288: E447 - E453.
65. 2. Surg Obes Relat Dis 2010; 6: 296 - 304.
66. Brolin RE, LaMarca LB, Kenler HA, Cody RP., Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195 - 205.
67. Hess DS, Hess DW, Oakley RS., The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15: 408 - 416.
68. Sugerman HJ., Bariatric surgery for severe obesity. J Assoc Acad Minor Phys 2001; 12: 129 - 136.
69. Korner J, Bessler M, Cirilo LJ, et al., Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90: 359 - 365.
70. Farilla L, Bulotta A, Hirshberg B, et al., Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 2003; 144: 5149 - 5158.
71. Kini S, Herron DM, Yanagisawa RT., Bariatric surgery for morbid obesity: a cure for metabolic syndrome? Med Clin North Am 2007; 91: 1255 - 1271.
72. Rubino F, R'bibo SL, del Genio F, et al., Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 2010; 6: 102 - 109.
73. Kellum JM, Kuemmerle JF, O'Dorisio TM, et al., Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763 - 770.
74. Cummings DE, Weigle DS, Frayo RS, et al., Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623 - 1630.
75. Reynolds CB, Elias AN, Whisnant CS., Effects of feeding pattern on ghrelin and insulin secretion in pigs. Domest Anim Endocrinol 2010; 39: 90 - 96.
76. Gasco V, Beccuti G, Marotta F, et al., Endocrine and metabolic actions of ghrelin. Endocr Dev 2010; 17: 86 - 95.
77. Ferzli GS, Dominique E, Ciaglia M, et al., Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 2009; 33: 972 - 979.
78. De Paula AL, Macedo AL, Rassi N, et al., Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 2008; 22: 2670 - 2678.
79. Withrow D, Alter DA., The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2010;doi:10.1111/j. 1467-789X.2009.00712.x.
80. Buchwald H, Avidor Y, Braunwald E, et al., Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724 - 1737.
81. Scopinaro N, Marinari GM, Camerini G., Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg 2002; 12: 362 - 365. (Pubitemid 34621031)
82. Sarson DL, Scopinaro N, Bloom SR., Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981; 5: 471 - 480.
83. Scopinaro N, Gianetta E, Civalleri D, et al., Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618 - 620. (Pubitemid 10224288)
84. Pories WJ, Albrecht RJ., Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001; 25: 527 - 531.
85. Rubino F, Gagner M., Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554 - 559.
86. 2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195 - 197.
87. Karamanakos SN, Vagenas K, Kalfarentzos F, et al., Weight loss, appetite suppression and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401 - 407.
88. Service GJ, Thompson GB, Service FJ, et al., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med 2005; 353: 249 - 254.
89. Huppertz E, Pieper L, Klotsche J, et al., Diabetes mellitus in German primary care: quality of glycaemic control and subpopulations not well controlled'results of the DETECT study. Exp Clin Endocrinol Diabetes 2009; 117: 6 - 14.